No valuation for Sonoma Biotherapeutics is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($265.0M) and the funding record below are the closest available signals.
- ·36 fund marks: filer, period, implied $/share
Membership and data by Private Market View
Sonoma Biotherapeutics funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2021 | Early Stage VC (Series B) | $265.0M | ▮ | ▮ |
Membership and data by Private Market View
Recent activity
In the last 90 days, Sonoma Biotherapeutics's record added 6 institutional fund marks (latest period Jul 2026).
How much has Sonoma Biotherapeutics raised?
Sonoma Biotherapeutics has raised $265 million across 1 recorded round since 2021. The largest was a $265 million Series B in Aug 2021.
Sonoma Biotherapeutics has filed 1 Form D with the SEC, most recently in Aug 2021 ($265 million sold to 40 investors).
Institutional holders and vehicles
2 SEC-registered funds reported 36 fair-value marks on Sonoma Biotherapeutics between Apr 2025 and Jul 2026, in their N-PORT filings. Filer-level marks and implied per-share values are available to Pro members.
How Sonoma Biotherapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Sonoma Biotherapeutics, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by institutional fund marks. Question about this number? Full methodology →
Frequently asked about Sonoma Biotherapeutics
- How much has Sonoma Biotherapeutics raised?
- Sonoma Biotherapeutics has raised $265.0M in total funding across 1 recorded rounds.
- When did Sonoma Biotherapeutics last raise?
- Sonoma Biotherapeutics last raised in Aug 2021 (Early Stage VC (Series B)), raising $265.0M.